Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit-Reference-Cited by-同舟云学术

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

Published:2010-12 Issue:1-3 Volume:649 Page:328-335
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Busby Robert W.,Bryant Alexander P.,Bartolini Wilmin P.,Cordero Etchell A.,Hannig Gerhard,Kessler Marco M.,Mahajan-Miklos Shalina,Pierce Christine M.,Solinga Robert M.,Sun Li Jing,Tobin Jenny V.,Kurtz Caroline B.,Currie Mark G.

Publisher

Elsevier BV

Subject

Pharmacology

Reference43 articles.

1. Gastrointestinal transit in mice treated with various extracts of date (Phoenix dactylifera L.);Al-Qarawi;Food Chem. Toxicol.,2003

2. Irritable bowel syndrome;Borum;Prim. Care Clin. Off. Pract.,2001

3. Different segmental transit times in patients with irritable bowel syndrome and “normal” colonic transit time: is there a correlation with symptoms?;Bouchoucha;Tech. Coloproctol.,2006

4. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract;Bryant;Life Sci.,2010

5. cGMP inhibition of Na+/H+antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein;Cha;J. Biol. Chem.,2005

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of linaclotide in bowel preparation for colonoscopy in patients with constipation: A prospective randomized controlled study;Journal of Gastroenterology and Hepatology;2024-09-09

2. Recent Progress on Transition Metal Catalyzed Macrocyclizations Based on C−H Bond Activation at Heterocyclic Scaffolds;Chemistry – An Asian Journal;2024-08-13

3. Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States;Clinical and Experimental Gastroenterology;2024-08

4. Examining linaclotide for the treatment of chronic idiopathic constipation;Expert Opinion on Pharmacotherapy;2024-07-02

5. DRA involvement in linaclotide-stimulated bicarbonate secretion during loss of CFTR function;JCI Insight;2024-06-13